Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics Revenue

Axsome Therapeutics had revenue of $104.76M in the quarter ending September 30, 2024, with 81.27% growth. This brings the company's revenue in the last twelve months to $338.46M, up 51.47% year-over-year. In the year 2023, Axsome Therapeutics had annual revenue of $270.60M with 440.80% growth.

• Revenue (ttm): $338.46M
• Revenue Growth: +51.47%
• P/S Ratio: 13.88
• Revenue / Employee: $621,022
• Employees: 545
• Market Cap: 4.78B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	270.60M	220.56M	440.80%
Dec 31, 2022	50.04M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.